Grail
grail.comGrail is a healthcare company focused on early cancer detection with a pan-cancer blood test that analyzes circulating tumor DNA (ctDNA) and other nucleic acids. Using advanced sequencing technology, it aims to detect cancers at early, treatable stages. Founded in 2016 by Alex Aravanis and Jeff Huber, Grail is based in Menlo Park, California, and has conducted large-scale clinical trials to validate its test.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the North Carolina Biotechnology Center network.
Something looks off?
Open jobs at Grail
On-site & Remote
Job function
Seniority
Salary